Last reviewed · How we verify
Intrapleural Medications
At a glance
| Generic name | Intrapleural Medications |
|---|---|
| Also known as | IPFT |
| Sponsor | Swedish Medical Center |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Impact of Intrapleural Block on Postoperative Pain Caused by Drainage Tubes After Thoracoscopic Surgery (NA)
- Intrapleural Alteplase-Tyloxapol vs Intrapleural Alteplase-DNase in Pleural Infection
- Fast TILs to Treat Metastatic Pleural Effusions From Epithelial or Mesothelial Primary Tumors (PHASE1)
- Pleural Irrigation With Normal Saline Versus Intrapleural Fibrinolytic (NA)
- Intrapleural Bupivacaine Analgesia for Postoperative Pain Management After Minimally Invasive Video-Assisted Thoracoscopic Surgery: A Randomized Controlled Trial (PHASE4)
- Intrapleural Photodynamic Therapy in a Multimodal Treatment for Patients With Malignant Pleural Mesothelioma (PHASE2)
- Fast TILs to Treat Metastatic Cancer Patients With Pleural Disease (PHASE1)
- First-in-Human Expanded Cohort Study of Intrapleural Administration of TolueneSulfonamide in Patients With Malignant Pleural Effusion (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intrapleural Medications CI brief — competitive landscape report
- Intrapleural Medications updates RSS · CI watch RSS
- Swedish Medical Center portfolio CI